INOVIQ (ASX:IIQ) Insider Purchases A$29,999.90 in Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston acquired 85,714 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was purchased at an average cost of A$0.35 per share, with a total value of A$29,999.90.

INOVIQ Stock Performance

The company has a current ratio of 7.07, a quick ratio of 9.52 and a debt-to-equity ratio of 2.02. The company has a market capitalization of $47.40 million, a PE ratio of -6.02 and a beta of 2.04.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.